Detail introduction: Etelcalcetide/1262780-97-1
| English name | Etelcalcetide |
| CAS NO | 1262780-97-1 |
| Peptide sequence | Ac-DCys-DAla-DArg-DArg-DArg-DAla-DArg-NH2(disulfide with L-cysteine hydrochloride) |
| Molecular formula | C38H73N21O10S2 |
| Molecular weight | 1048.25 |
| storage temperature | 2-8℃ |
| purity | ≥98% |
| Package | 1mg;5mg;10mg;50mg;100mg,1g or according to customer’s detail requirement. |
| Product English synonyms | D-Argininamide, N-acetyl-D-cysteinyl-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-alanyl-, disulfide with L-cysteine |
How can Etelcalcetide be used in medicine?
Etelcalcetide is a novel CalcimimeticAgent, which is administered intravenously and developed for chronic kidney disease (CKD) patients undergoing hemodialysis treatment. AMG416 binds to and activates the calcium-sensitive receptors on the parathyroid glands, resulting in a reduction in the level of parathyroid hormone (PTH). Verakatide can be used to treat hyperparathyroidism.
Applications and production process of Etelcalcetide peptide
Etelcalcetide, also called Veracatide, is a novel CalcimimeticAgent (CalcimimeticAgent) for the treatment of hyperparathyroidism. It is administered intravenously and developed for patients with chronic kidney disease (CKD) undergoing hemodialysis.
The U.S. Food and Drug Administration (FDA) approved Etelcalcetide for the treatment of secondary hyperparathyroidism in adult hemodialysis patients, the first drug approved for the treatment of secondary hyperparathyroidism in dialysis patients in 12 years. In patients with moderate to severe hyperparathyroidism on hemodialysis, the level of PTH decreased significantly after treatment with Veracatide.
How to buy etelcalcetide peptide in the U. S.
Peptide supplier Remetide specializes in the production and sales of peptides in the USA, as well as Professional Drug peptide R&D. Feel free to contact Remetide if you have any questions or inquiries about Etelcalcetide Peptides.